Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial

by Taro Mawatari, Satoshi Ikemura, Gen Matsui, Takahiro Iguchi, Hiroaki Mitsuyasu, Shinya Kawahara, Masayuki Maehara, Ryoichi Muraoka, Yukihide Iwamoto, Yasuharu Nakashima
Published 2020-06-01